Drug Search Results
More Filters [+]

Serrapeptase

Alternative Names: serrapeptase, serratiopeptidase
Latest Update: 2024-06-25
Latest Update Note: News Article

Product Description

Mechanisms of Action: N/A

Novel Mechanism: No

Modality: Peptide/Protein

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Chile | Dominican Republic | Ecuador | Germany | Greece | Hong Kong | India | Italy | Jordan | Korea | Lebanon | Malaysia | Mexico | Morocco | Pakistan | Peru | Portugal | Taiwan | Ukraine | United Arab Emirates | United Kingdom | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: Hayat
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Serrapeptase

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 4: Inflammation|Trismus

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Ser.01

P4

Unknown status

Trismus|Inflammation

2016-01-01

Recent News Events